Jesus B. Mantas's most recent trade in Biogen Inc was a trade of 2,370 Common Stock done . Disclosure was reported to the exchange on June 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biogen | Jesus B. Mantas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 2,370 | 9,758 (0%) | 0% | 0 | Common Stock | |
| Biogen | Jesus B. Mantas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 1,340 | 7,388 (0%) | 0% | 0 | Common Stock | |
| Biogen | Jesus B. Mantas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 960 | 6,048 (0%) | 0% | 0 | Common Stock | |
| Biogen | Jesus B. Mantas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 1,370 | 5,088 (0%) | 0% | 0 | Common Stock | |
| Biogen | Jesus B. Mantas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 775 | 3,718 (0%) | 0% | 0 | Common Stock | |
| Biogen | Jesus B. Mantas | Director | Purchase of securities on an exchange or from another person at price $ 267.00 per share. | 09 Feb 2021 | 898 | 2,943 (0%) | 0% | 267 | 239,766 | Common Stock |